Skip to content

As The COVID-19 Vaccine Competition Heats Up, Consider These Biotech Stocks & ETFs

As the number of those infected with COVID-19 goes up domestically and globally, the competition to develop a vaccine is heating up – and the author of today’s article observes that “The continuous competition to introduce vaccine for the COVID-19 is springing near-term opportunities, making the biotech sector a prospective space for investments.” For a number of specific biotech stocks and ETFs to consider for exposure to the sector, CLICK HERE.